Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

FBLG

FibroBiologics (FBLG)

FibroBiologics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:FBLG
日付受信時刻ニュースソース見出しコード企業名
2024/05/1605 : 30GlobeNewswire Inc.FibroBiologics Announces 2024 Annual Meeting of StockholdersNASDAQ:FBLGFibroBiologics Inc
2024/05/1605 : 02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FBLGFibroBiologics Inc
2024/05/1506 : 24GlobeNewswire Inc.FibroBiologics Files 2024 First Quarter ReportNASDAQ:FBLGFibroBiologics Inc
2024/05/1505 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
2024/05/0722 : 31GlobeNewswire Inc.FibroBiologics to Present at the BIO International Convention 2024NASDAQ:FBLGFibroBiologics Inc
2024/04/2521 : 00GlobeNewswire Inc.FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based SpheroidsNASDAQ:FBLGFibroBiologics Inc
2024/04/1122 : 31GlobeNewswire Inc.FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeNASDAQ:FBLGFibroBiologics Inc
2024/04/0422 : 31GlobeNewswire Inc.FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
2024/03/2822 : 31GlobeNewswire Inc.FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of LupusNASDAQ:FBLGFibroBiologics Inc
2024/03/1922 : 31PR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
2024/03/1922 : 31PR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
2024/03/1322 : 31PR Newswire (US)FibroBiologics to Present at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
2024/03/0623 : 31PR Newswire (US)FibroBiologics Appoints Ruben A. Garcia as General CounselNASDAQ:FBLGFibroBiologics Inc
2024/03/0107 : 44PR Newswire (US)FibroBiologics Files 2023 Form 10-K Annual ReportNASDAQ:FBLGFibroBiologics Inc
2024/02/2023 : 31PR Newswire (US)FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) ForumNASDAQ:FBLGFibroBiologics Inc
2024/02/1323 : 31PR Newswire (US)FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory DiseasesNASDAQ:FBLGFibroBiologics Inc
2024/02/0823 : 31PR Newswire (US)FibroBiologics Announces Three United States Patents for Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
2024/02/0623 : 31PR Newswire (US)FibroBiologics Announces Three Japanese Patents on Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
 Showing the most relevant articles for your search:NASDAQ:FBLG

最近閲覧した銘柄

Delayed Upgrade Clock